Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06514534 |
| Title | Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib. (ASC4TARGET) |
| Acronym | ASC4TARGET |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | RECRUITING | Bordeaux | 33076 | France | Details | |
| Novartis Investigative Site | RECRUITING | Lille | 59037 | France | Details | |
| Novartis Investigative Site | RECRUITING | Lyon | 69373 | France | Details | |
| Novartis Investigative Site | RECRUITING | Nantes | 44093 | France | Details | |
| Novartis Investigative Site | RECRUITING | Paris | 75475 | France | Details | |
| Novartis Investigative Site | RECRUITING | Vandœuvre-lès-Nancy | 54511 | France | Details |